Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Jul;26(1):65–68. doi: 10.1128/aac.26.1.65

Effects of topical applications of phosphonoacetate on colonization of mouse trigeminal ganglia with herpes simplex virus type 1.

R J Klein, A E Friedman-Kien, L Kaley, E Brady
PMCID: PMC179918  PMID: 6089655

Abstract

The effects of topical application of phosphonoacetic acid on the colonization of mouse trigeminal ganglia by herpes simplex virus type 1 were examined. The results showed that the extent of colonization of ganglia by virus is related to the time elapsed between virus inoculation and application of this agent. In most cases, treatment started up to 12 h after inoculation prevented invasion of ganglia by virus. When started up to 24 h after inoculation, treatment reduced and stabilized the amount of virus detectable in trigeminal ganglia during the acute phase of the ganglionic infection. Treatments started 24 h after virus inoculation had little influence on total virus accumulations in trigeminal ganglia. The data also indicate that virus titers in specimens of inoculated and treated skin sites are less affected by topical phosphonoacetic acid treatment than virus titers in ganglia. The experiments may represent a model system for testing effects of other antiviral compounds on colonization of ganglia by virus and may provide some clues regarding the pathogenic mechanism of herpes simplex virus infections.

Full text

PDF
65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook M. L., Stevens J. G. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect Immun. 1973 Feb;7(2):272–288. doi: 10.1128/iai.7.2.272-288.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Klein R. J., DeStefano E., Brady E., Friedman-Kien A. E. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice. Antimicrob Agents Chemother. 1979 Sep;16(3):266–270. doi: 10.1128/aac.16.3.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Klein R. J., DeStefano E. Dissemination of herpes simplex virus in ganglia after footpad inoculation in neurectomized and non-neurectomized mice. Arch Virol. 1983;77(2-4):231–238. doi: 10.1007/BF01309270. [DOI] [PubMed] [Google Scholar]
  4. Klein R. J., Friedman-Kien A. E., DeStefano E. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine. Antimicrob Agents Chemother. 1979 May;15(5):723–729. doi: 10.1128/aac.15.5.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klein R. J., Friedman-Kien A. E. Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate. Antimicrob Agents Chemother. 1977 Nov;12(5):577–581. doi: 10.1128/aac.12.5.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Knotts F. B., Cook M. L., Stevens J. G. Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J Infect Dis. 1974 Jul;130(1):16–27. doi: 10.1093/infdis/130.1.16. [DOI] [PubMed] [Google Scholar]
  7. Kristensson K., Lycke E., Sjöstrand J. Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol. 1971;17(1):44–53. doi: 10.1007/BF00684740. [DOI] [PubMed] [Google Scholar]
  8. Kristensson K., Vahlne A., Persson L. A., Lycke E. Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculation. J Neurol Sci. 1978 Feb;35(2-3):331–340. doi: 10.1016/0022-510x(78)90013-8. [DOI] [PubMed] [Google Scholar]
  9. Lascano E. F., Berria M. I. Histological study of the progression of herpes simplex virus in mice. Arch Virol. 1980;64(1):67–79. doi: 10.1007/BF01317392. [DOI] [PubMed] [Google Scholar]
  10. Lycke E., Kristensson K., Svennerholm B., Vahlne A., Ziegler R. Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J Gen Virol. 1984 Jan;65(Pt 1):55–64. doi: 10.1099/0022-1317-65-1-55. [DOI] [PubMed] [Google Scholar]
  11. Pavan-Langston D., Park N. H., Hettinger M. Ganglionic herpes simplex and systemic acyclovir. Arch Ophthalmol. 1981 Aug;99(8):1417–1419. doi: 10.1001/archopht.1981.03930020291019. [DOI] [PubMed] [Google Scholar]
  12. Stanberry L. R., Kern E. R., Richards J. T., Abbott T. M., Overall J. C., Jr Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. J Infect Dis. 1982 Sep;146(3):397–404. doi: 10.1093/infdis/146.3.397. [DOI] [PubMed] [Google Scholar]
  13. Trousdale M. D., Dunkel E. C., Nesburn A. B. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit. Invest Ophthalmol Vis Sci. 1980 Nov;19(11):1336–1341. [PubMed] [Google Scholar]
  14. Wohlenberg C. R., Walz M. A., Notkins A. L. Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia. Infect Immun. 1976 May;13(5):1519–1521. doi: 10.1128/iai.13.5.1519-1521.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES